{"id":"https://openalex.org/W4309858876","doi":"https://doi.org/10.3389/fonc.2022.1058726","title":"MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma","display_name":"MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma","publication_year":2022,"publication_date":"2022-11-24","ids":{"openalex":"https://openalex.org/W4309858876","doi":"https://doi.org/10.3389/fonc.2022.1058726","pmid":"https://pubmed.ncbi.nlm.nih.gov/36505784","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9730801"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.1058726","doi":"https://doi.org/10.3389/fonc.2022.1058726","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.1058726","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.1058726/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.1058726/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100338067","display_name":"Tao Liu","orcid":"https://orcid.org/0000-0001-6244-7316","observed_orcids":["https://orcid.org/0000-0001-6244-7316","https://orcid.org/0000-0002-8818-8313"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Liu","raw_affiliation_strings":["Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108694212","display_name":"Lubing Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lubing Gu","raw_affiliation_strings":["Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111200474","display_name":"Zhongzhi Wu","orcid":"https://orcid.org/0000-0002-4511-3119","observed_orcids":["https://orcid.org/0000-0002-4511-3119"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhongzhi Wu","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043230785","display_name":"Najah G. Albadari","orcid":"https://orcid.org/0000-0002-9738-4519","observed_orcids":["https://orcid.org/0000-0002-9738-4519"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Najah Albadari","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100511441","display_name":"Muxiang Zhou","orcid":"https://orcid.org/0000-0002-2058-1645","observed_orcids":["https://orcid.org/0000-0002-2058-1645"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Muxiang Zhou","raw_affiliation_strings":["Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100511441"],"corresponding_institution_ids":["https://openalex.org/I150468666"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.2609,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.54318043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"1058726","last_page":"1058726"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.012199999764561653,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mycn","display_name":"MYCN","score":0.8500000238418579},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/mycn-amplification","display_name":"MYCN amplification","score":0.7630000114440918},{"id":"https://openalex.org/keywords/mrna-degradation","display_name":"mRNA degradation","score":0.7900000214576721},{"id":"https://openalex.org/keywords/3-untranslated-region","display_name":"3' untranslated region","score":0.7580000162124634},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8730000257492065},{"id":"https://openalex.org/keywords/let-7-microrna","display_name":"let-7 microRNA","score":0.9409999847412109},{"id":"https://openalex.org/keywords/dicer1","display_name":"DICER1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/arid3b","display_name":"ARID3B","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hmga2","display_name":"HMGA2","score":1.0},{"id":"https://openalex.org/keywords/tumor-suppressor-microrna","display_name":"tumor suppressor microRNA","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.858642578125},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.6576867699623108},{"id":"https://openalex.org/C89604277","wikidata":"https://www.wikidata.org/wiki/Q424345","display_name":"Untranslated region","level":4,"score":0.6187273263931274},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6061717867851257},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5203865766525269},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.5109474062919617},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.504815399646759},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4305609464645386},{"id":"https://openalex.org/C22667442","wikidata":"https://www.wikidata.org/wiki/Q3272830","display_name":"Three prime untranslated region","level":5,"score":0.4169995188713074},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3792131543159485},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3027597665786743},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1505170464515686}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.1058726","doi":"https://doi.org/10.3389/fonc.2022.1058726","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.1058726","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.1058726/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9730801","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9730801","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:36505784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36505784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:937dacf25a24413bba8b9ec93921e6f2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/937dacf25a24413bba8b9ec93921e6f2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.1058726","doi":"https://doi.org/10.3389/fonc.2022.1058726","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.1058726","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.1058726/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307428","display_name":"Rally Foundation","ror":"https://ror.org/01mkym489"},{"id":"https://openalex.org/F4320337586","display_name":"Hyundai Hope On Wheels","ror":"https://ror.org/01f6q3121"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4309858876.pdf","grobid_xml":"https://content.openalex.org/works/W4309858876.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W172433167","https://openalex.org/W1902445142","https://openalex.org/W1966524607","https://openalex.org/W1986933266","https://openalex.org/W1988105611","https://openalex.org/W2002807817","https://openalex.org/W2029706883","https://openalex.org/W2047038623","https://openalex.org/W2062500929","https://openalex.org/W2064428081","https://openalex.org/W2089585111","https://openalex.org/W2092663839","https://openalex.org/W2098282574","https://openalex.org/W2103184621","https://openalex.org/W2103639574","https://openalex.org/W2130314846","https://openalex.org/W2132834292","https://openalex.org/W2151041413","https://openalex.org/W2168062283","https://openalex.org/W2170647698","https://openalex.org/W2237104849","https://openalex.org/W2327522594","https://openalex.org/W2329830099","https://openalex.org/W2473839227","https://openalex.org/W2522678060","https://openalex.org/W2735002155","https://openalex.org/W3015021067","https://openalex.org/W3209991018","https://openalex.org/W4295560443","https://openalex.org/W6639827826"],"related_works":["https://openalex.org/W2054264153","https://openalex.org/W1988105611","https://openalex.org/W4406367180","https://openalex.org/W2027022682","https://openalex.org/W3158639418","https://openalex.org/W2473839227","https://openalex.org/W2981672224","https://openalex.org/W1966524607","https://openalex.org/W1984767861","https://openalex.org/W2066909301"],"abstract_inverted_index":{"Amplification":[0],"of":[1,17,33,55,85,95,103,114,125,133,148,159,164,172,187,218,233],"the":[2,11,31,37,53,83,92,99,104,134,146,162,183,230],"MYCN":[3,18,34,56,60,76,86,115,126,143,188,209,219],"gene":[4,192],"leads":[5],"to":[6,50,52,91,175,191],"its":[7],"overexpression":[8,124,186],"at":[9],"both":[10,222],"mRNA":[12,19,57,61,127,144,189,210],"and":[13,58,69,101,140,151,168,202,205,228],"protein":[14],"levels.":[15],"Overexpression":[16],"may":[20,211],"also":[21],"have":[22],"an":[23,195,213],"important":[24],"role":[25,84],"in":[26,65,73,89,117,155,198],"promoting":[27],"neuroblastoma":[28],"(NB)":[29],"beyond":[30],"translation":[32],"protein.":[35],"In":[36],"present":[38],"study,":[39],"we":[40,97],"report":[41],"a":[42,112],"small":[43],"molecule":[44],"compound":[45],"(MX25-1)":[46],"that":[47,123,185,207],"was":[48,128,153],"able":[49],"bind":[51],"3\u2019UTR":[54,77,116],"induce":[59],"degradation;":[62],"this":[63,180],"resulted":[64],"potent":[66],"cell-growth":[67],"inhibition":[68],"cell":[70,200],"death":[71],"specifically":[72],"MYCN-amplified":[74,118],"or":[75],"overexpressing":[78],"NB":[79,173,199],"cells.":[80,157],"To":[81],"evaluate":[82],"3\u2019UTR-mediated":[87],"signals":[88],"contributing":[90],"anticancer":[93],"activity":[94],"MX25-1,":[96],"examined":[98],"status":[100],"activation":[102],"tumor":[105],"suppressor":[106],"microRNA":[107],"(miRNA)":[108],"let-7,":[109],"which":[110],"is":[111],"target":[113],"NB.":[119],"We":[120],"first":[121],"observed":[122],"associated":[129],"with":[130],"high-level":[131],"expression":[132,147],"let-7":[135,160],"oncogenic":[136,166],"targets":[137],"DICER1,":[138,149],"ARID3B":[139,150],"HMGA2.":[141],"Following":[142],"degradation,":[145],"HMGA2":[152],"downregulated":[154],"MX25-1-treated":[156],"Inhibition":[158],"reversed":[161],"downregulation":[163],"these":[165],"mRNAs":[167],"significantly":[169],"increased":[170],"resistance":[171],"cells":[174],"MX25-1.":[176],"Our":[177],"results":[178],"from":[179],"study":[181],"supported":[182],"notion":[184],"due":[190],"amplification":[193],"has":[194],"independent":[196],"function":[197],"growth":[201],"disease":[203],"progression":[204],"suggest":[206],"targeting":[208],"represent":[212],"attractive":[214],"strategy":[215],"for":[216],"therapy":[217],"amplified":[220],"NB,":[221],"by":[223],"inhibiting":[224],"MYCN\u2019s":[225],"cell-survival":[226],"effects":[227],"activating":[229],"tumor-suppressor":[231],"effect":[232],"let-7.":[234]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-11-29T00:00:00"}